Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,523,030 papers from all fields of science
Search
Sign In
Create Free Account
Osteoporosis, Postmenopausal
Known as:
Postmenopausal Bone Losses
, Bone Losses, Perimenopausal
, Osteoporoses, Post-Menopausal
Expand
Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
46 relations
10 ML Pamidronate Disodium 3 MG/ML Injection
10 ML Pamidronate Disodium 9 MG/ML Injection
84 HR Estradiol 0.00156 MG/HR Transdermal System [Vivelle]
84 HR Estradiol 0.00208 MG/HR Transdermal System [Alora]
Expand
Broader (1)
Osteoporosis
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Relationship Between Osteoporosis and Cardiovascular Disease in Postmenopausal Women
L. Tankó
,
C. Christiansen
,
D. Cox
,
M. Geiger
,
M. McNabb
,
S. Cummings
Journal of Bone and Mineral Research
2005
Corpus ID: 403192
In the placebo group of the MORE study, including 2576 postmenopausal women (mean age, 66.5 years), the authors describe a strong…
Expand
Highly Cited
2002
Highly Cited
2002
Meta-Analyses of Therapies for Postmenopausal Osteoporosis
A. Cranney
,
P. Tugwell
,
+14 authors
D. Henry
2002
Corpus ID: 57880380
III. Risedronate Ann Cranney, MD, MSc; Peter Tugwell, MD, MSc; Jonathan Adachi, MD; Bruce Weaver, MSc; Nicole Zytaruk, RN…
Expand
Review
2002
Review
2002
Complementary and Alternative Medicine for Menopausal Symptoms: A Review of Randomized, Controlled Trials
F. Kronenberg
,
A. Fugh-Berman
Annals of Internal Medicine
2002
Corpus ID: 9268865
Women are frequent users of complementary and alternative medicine (CAM) therapies in many countries (1-5), including the United…
Expand
Review
1998
Review
1998
Treatment of postmenopausal osteoporosis.
R. Eastell
New England Journal of Medicine
1998
Corpus ID: 40106429
Osteoporosis affects an estimated 75 million people in Europe, the United States, and Japan.1 It is a preventable and treatable…
Expand
Highly Cited
1998
Highly Cited
1998
Treatment of Established Postmenopausal Osteoporosis with Raloxifene: A Randomized Trial
E. Lufkin
,
M. Whitaker
,
+4 authors
B. Riggs
Journal of Bone and Mineral Research
1998
Corpus ID: 2495500
Raloxifene is a selective estrogen receptor modulator that in experimental animals acts as an estrogen receptor antagonist in…
Expand
Highly Cited
1989
Highly Cited
1989
COST OF INJURY IN THE UNITED STATES: A REPORT TO CONGRESS
D. Rice
,
E. Mackenzie
,
+8 authors
Gordon S. Smith
1989
Corpus ID: 68749204
In 1987, Congress directed that research be conducted to evaluate the impact of injury and associated disability on the United…
Expand
Highly Cited
1987
Highly Cited
1987
Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study.
B. Riis
,
K. Thomsen
,
C. Christiansen
New England Journal of Medicine
1987
Corpus ID: 7555586
During a two-year study, we examined the effect of calcium supplementation on postmenopausal bone loss in 43 women in the early…
Expand
Highly Cited
1983
Highly Cited
1983
[Postmenopausal osteoporosis].
R. Eliakim
,
A. Foldes
,
J. Menczel
Harefuah
1983
Corpus ID: 2944945
Highly Cited
1980
Highly Cited
1980
Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.
J. Gallagher
,
B. Riggs
,
H. DeLuca
Journal of Clinical Endocrinology and Metabolism
1980
Corpus ID: 24665447
Osteoporotic women have decreased calcium absorption and decreased serum 1,25-dihydroxyvitamin D [1,25-(OH)2D] and are usually in…
Expand
Highly Cited
1971
Highly Cited
1971
Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal females
C. Christiansen
,
M. S. Christensen
,
P. Mcnair
,
C. Hagen
,
K. Stocklund
,
I. Transbøl
European Journal of Clinical Investigation
1971
Corpus ID: 22431643
Abstract. With the aim of preventing postmenopausal bone loss, a placebo‐controlled double‐blind trial of 2 years duration was…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE